Story type: Industry

  • Childhood Cancer Research Symposium: Cutting-edge science advancing childhood cancer treatment

    More than 150 leading clinicians and scientists heard from national and international experts in childhood cancer at Hudson Institute of Medical Research on Wednesday, 13 February at a highly anticipated international symposium. The symposium was made possible through the generous support of our premium partner, the Children’s Cancer Foundation, along with the Isabella and Marcus…  Read more

    Symposium Lanyards - More than 150 leading clinicians and scientists heard from experts in childhood cancer at the Childhood Cancer Research Symposium.
  • Next Big Idea Award winners announced

    Researchers and students have pitched their innovative ‘Big Ideas’ tackling health conditions ranging from tackling Legionnaires disease to improving exercise science to a panel of research and commercialisation experts. It was all part of the Next Big Idea Award on August 30, which aims to encourage, reward and facilitate commercially focused innovation among our PhD…  Read more

    L-R: Dr Michael Gantier, Stuart Emmerson, Dr Nick Boyd and Dr Shivani Pasricha at the Next Big Idea Awards.
  • Turbo-charging chemotherapy for lung cancer

    A naturally occurring hormone could help make chemotherapy much more effective for many Australians with lung cancer, according to new findings from Sydney and Melbourne researchers. And the hormone – known as follistatin – also appears to prevent kidney damage, a serious side effect of chemotherapy. The promising new ‘two birds, one stone’ treatment approach, which was…  Read more

  • Sparking the skills to take research to industry

    PhD student, Anqi Li has been selected to take part in the prestigious SPARK Biomedical Innovation and Entrepreneurship training course in Berlin, Germany this month. The two-week intensive course aims to bridge the gap between industry and academia by helping PhD students to think in creative, innovative and entrepreneurial ways.  It is part of the…  Read more

  • Lifesaving ‘off-the-shelf’ cancer tracking immunotherapies underway

    ‘Off-the-shelf’ immunotherapies to fight aggressive forms of cancer, including relapsed ovarian and gastric cancers, are being developed in Clayton, Melbourne, thanks to almost $3 million in Federal Government funding awarded to lead participant Cartherics Pty Ltd. Hudson Institute of Medical Research and Monash University researchers are partnering with industry leaders in cell therapies to develop…  Read more

    Professor Alan Trounson
  • Melbourne innovation set to revolutionise cell therapy industry

    A world-leading Melbourne innovation is rapidly changing the way cell therapies are manufactured to treat diseases including stroke and cerebral palsy, taking these treatments out of the lab and into hospitals. The new cell-processing technology, ROTEA, developed by Melbourne start-up, Scinogy in conjunction with Hudson Institute of Medical Research, is significantly reducing the costs and…  Read more

    A Melbourne innovation is rapidly changing the way cell therapies are manufactured to treat diseases including stroke & cerebral palsy.
  • Hudson Institute enters into research alliance with Invion Limited

    Hudson Institute has entered into a Research and Development Alliance Agreement with Invion Limited to provide key scientific assessment of Invion’s cancer treatment technology, Photosoft. The collaboration will initially focus on the treatment of ovarian cancer, with a view to expanding research and development projects into other forms of cancer. Hudson Institute will provide the…  Read more

  • Childhood cancer ‘organoid’ program set to revolutionise treatment

    The Hudson Monash Precision Medicine Program hopes to significantly improve treatment for childhood cancer patients with the greatest unmet clinical need – those diagnosed with brain cancers and solid tumours. Launched today (February 7) ahead of International Childhood Cancer Day on February 15, the two year program is being established with a $1.3 million investment…  Read more

  • When science meets innovation: cell therapies

    Leading Australian stem cell researcher, Dr Rebecca Lim has just returned from Toronto, the global centre of cell therapies research and a hotbed of innovation and start-ups. She shares what happens when science meets innovation and commercialisation. You’ve just been to Toronto, Canada to visit the Centre for Commercialisation of Regenerative Medicine. What was the…  Read more

  • Next Big Idea Award winners announced

    Five innovative ‘Big Ideas’ were presented by PhD students and early career researchers (ECRs) from Hudson Institute on August 17 to a panel of expert judges from industry, research and business development, with prizes and mentoring for the best and runner-up ideas. Projects pitched included two new diagnostic tests – one for autoimmune disease and another for infectious…  Read more